Diaphragm Neurostimulation System

About Stimdia Medical

Stimdia Medical is pioneering a novel therapeutic approach for patients with chronic respiratory insufficiency due to diaphragm paralysis. Its core technology is an implantable neurostimulation system that interfaces with the phrenic nerve, offering a potential alternative to long-term mechanical ventilation. As a private, pre-revenue company, it is likely in the development and early clinical stages, targeting a significant unmet need within the respiratory care market. Success hinges on clinical validation, regulatory clearance, and adoption by thoracic surgeons and pulmonologists.

Therapeutic Areas